Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial
Titel:
Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial
Auteur:
Giganti, Mark J. Chew, Kara W. Moser, Carlee Eron, Joseph J. Pinilla, Mauricio Li, Jonathan Z. Ritz, Justin Javan, Arzhang Cyrus Wohl, David Alain Daar, Eric S. Currier, Judith S. Smith, Davey M. Hughes, Michael D.